Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fluorine-18 PBR 06

Next Previous
Drug Profile

Fluorine-18 PBR 06

Alternative Names: [18F]PBR06; [18F]PBR06 PET

Latest Information Update: 04 Apr 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Molecular NeuroImaging
  • Developer Molecular NeuroImaging; Novartis
  • Class Amides; Fluorine compounds; Imaging agents; Phenyl ethers; Radiopharmaceutical diagnostics; Small molecules
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Multiple sclerosis
  • No development reported Amyotrophic lateral sclerosis

Most Recent Events

  • 24 Feb 2022 Efficacy data from a phase III trial in multiple sclerosis presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Forum (ACTRIMS-2022)
  • 28 Oct 2020 No recent reports of development identified for phase-I development in Amyotrophic-lateral-sclerosis(Diagnosis) in USA (Parenteral, Injection)
  • 21 Sep 2020 Phase-III clinical trials in Multiple sclerosis (Diagnosis, Recurrent) in USA (SC) (NCT04510220)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top